C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	EP1212298A4 Isolation of natural l-beta-3-indolylalanine and enrichment of natural aliphatic amino acid mixtures with natural l-beta-3-indolylalanine
10/24/2002	DE10119804A1 New peptides produced in primates during inflammation and sepsis, useful for diagnosis and treatment of these diseases, and their related antibodies
10/24/2002	CA2445990A1 Full-length human cdnas encoding potentially secreted proteins
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444298A1 Method for enhancing the translation and expression of recombinant proteins
10/24/2002	CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002	CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
10/24/2002	CA2444047A1 Methods to inhibit viral replication
10/24/2002	CA2443995A1 Endothelial cell expression patterns
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443570A1 Methods using o6-alkylguanine-dna alkyltransferases
10/24/2002	CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections
10/24/2002	CA2443493A1 Surface proteins of streptococcus pyogenes
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2440846A1 Protein cluster v
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2430322A1 Use of clya hemolysin for excretion of proteins
10/23/2002	EP1251175A1 Method for diversifying the chemical composition of protein produced in vivo by genetically disabling the editing function of their aminoacyl tRNA synthetases
10/23/2002	EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/23/2002	EP1250918A1 Cosmetic compositions containing archaebacteria extracts
10/23/2002	EP1250458A2 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
10/23/2002	EP1250444A1 Methods for producing a polypeptide using a consensus translational initiator sequence
10/23/2002	EP1250439A1 Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250420A2 Techniques for growth and differentiation of human pluripotent stem cells
10/23/2002	EP1250154A2 G-csf conjugates
10/23/2002	EP0909278A4 Nephropathy-related immunoglobulin g and antibodies for same
10/23/2002	EP0865498B1 Process for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms
10/23/2002	EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/23/2002	EP0721470B1 Monoclonal antibodies for use in diagnosis and treatment of colorectal cancer
10/23/2002	EP0642581B1 Clostridium perfringens vaccines
10/23/2002	EP0576623B1 Binding domains in notch and delta proteins
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376166A Peptide that lower blood glucose levels
10/23/2002	CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/23/2002	CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/22/2002	US6469230 Starch debranching enzymes
10/22/2002	US6469145 One-step purification process for organophosphorus hydrolase enzyme
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469142 Components of nmda receptors that have cation-selective channels and bind glutamate and nmda (n-methyl-d-aspartate)
10/22/2002	US6469140 Molecules of the card-related protein family and uses thereof
10/22/2002	US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002	US6468777 Through enhanced control and stabilization of protein production via stress proteins and the resultant protein products
10/22/2002	US6468775 From a thermophilic eubacterium; polymerase shows magnesium ion dependent reverse transcriptase activity and 3'-5' exonuclease activity
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468750 Cell regulation factor TTO 20
10/22/2002	US6468738 First polypeptide fused to a filamentous phage membrane cpviii anchor domain; mutating immunoglobulin variable domain-coding nucleotide sequence in the provided genome to form library of phage particles; immunoglobulin vh polypeptide (antibody heavy
10/22/2002	US6468540 Immunotherapeutic stress protein-peptide complexes against cancer
10/22/2002	US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468476 Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
10/22/2002	CA2243598C Cold-active protease cp70
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002	CA2095335C Cell growth inhibitors
10/22/2002	CA2040437C Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor
10/22/2002	CA1341395C Preparation of functional human factor viii
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081731A2 Novel nucleic acids and polypeptides
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081694A1 Method for the sectetion and production of protein
10/17/2002	WO2002081690A1 Novel protein, dna thereof and use of the same
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081650A2 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081523A2 Method for preparing and selecting antibodies
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081507A2 Interferon gamma polypeptide variants
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002081490A2 Computer-directed assembly of a polynucleotide encoding a target polypeptide
10/17/2002	WO2002080848A2 Methods and materials for cancer treatment
10/17/2002	WO2002080847A2 Use of tumor necrosis factor inhibitors to treat cardiovascular disease
10/17/2002	WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080842A2 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002004489A9 Polymorphic kinase anchor proteins and nucleic acids encoding the same
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001081551A3 Retinal pigment epithelial cell lines with extended life-span and their applications
10/17/2002	WO2001053330A9 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	US20020152496 Coleopteran toxin proteins of bacillus thuringiensis
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020151708 DNA encoding proteins that inhibit Hsp70 function
10/17/2002	US20020151706 Antiinflammatory agents

1 ... 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 ... 1125